Helen J. Lachmann
- Nephrology top 0.05%
- Parathyroid Disorders and Treatments 65
- Hematology top 0.2%
- Autoimmune and Inflammatory Disorders Research 33
- Molecular Biology top 0.2%
- Amyloidosis: Diagnosis, Treatment, Outcomes 211
- Inflammasome and immune disorders 104
- Rheumatology top 0.2%
- Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 19
-
- Neuroendocrine Tumor Research Advances 26
-
- IL-33, ST2, and ILC Pathways 25
- Immune Cell Function and Interaction 18
- Co-authors
- Philip N. HawkinsJulian D. GillmoreAshutosh WechalekarCarol WhelanJanet A. GilbertsonDorota RowczenioThirusha LaneMarianna Fontana
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Helen J. Lachmann
314 papers receiving 12.7k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Nephrology 3.3k
- Hematology 2.3k
- Molecular Biology 11.0k
- Rheumatology 2.1k
- Genetics 1.4k
Countries citing papers authored by Helen J. Lachmann
This map shows the geographic impact of Helen J. Lachmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen J. Lachmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen J. Lachmann more than expected).
Fields of papers citing papers by Helen J. Lachmann
This network shows the impact of papers produced by Helen J. Lachmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen J. Lachmann. The network helps show where Helen J. Lachmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Helen J. Lachmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 20 | |
| 11 | 2021 | 42 | |
| 12 | 2012 | 197 | |
| 13 | Efficacy and Safety of Canakinumab in Patients with TNF Receptor Associated Periodic Syndrome | 2012 | 8 |
| 14 | The Emerging Role of Interleukin-1 beta in Autoinflammatory Diseases | 2011 | 1 |
| 15 | Localised amyloid at injection sites derived from porcine and human insulin | 2010 | 1 |
| 16 | 2010 | 7 | |
| 17 | Amyloidosis and the Skin | 2010 | 3 |
| 18 | Treatment of cryopyrin associated periodic fever syndrome with a fully human anti-IL-1beta monoclonal antibody (ACZ885): results from a subcutaneous administration study | 2008 | 4 |
| 19 | Natural history and outcome of amyloidosis in the elderly | 2006 | 1 |
| 20 | Combination chemotherapy for systemic AL amyloidosis | 2001 | 1 |
About Helen J. Lachmann
Helen J. Lachmann is a scholar working on Nephrology, Hematology and Molecular Biology, having authored 335 papers that have together received 13.0k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (211 papers), Inflammasome and immune disorders (104 papers), Parathyroid Disorders and Treatments (65 papers), Autoimmune and Inflammatory Disorders Research (33 papers), Neuroendocrine Tumor Research Advances (26 papers), IL-33, ST2, and ILC Pathways (25 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers) and Immune Cell Function and Interaction (18 papers). The work is most often cited by research in Nephrology (3.3k citations), Hematology (2.3k citations) and Molecular Biology (11.0k citations). Helen J. Lachmann has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Philip N. Hawkins, Julian D. Gillmore, Ashutosh Wechalekar, Carol Whelan, Janet A. Gilbertson, Dorota Rowczenio, Thirusha Lane, Marianna Fontana, Jennifer H. Pinney and Michael McDermott. Their work appears in journals such as New England Journal of Medicine, The Lancet and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.